Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
![](https://fprimecapital.com/wp-content/uploads/2019/01/alternate-healthcare-illustration-1024x1024.jpg)
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
PR Newswire
Indalo Therapeutics Presents Phase 1 Clinical Trial Results for Lead Antifibrotic Drug Candidate IDL-2965
November 11, 2019 -
BioSpace
Hua Medicine to Release Phase III 24-Weeks Topline Data of Dorzagliatin Monotherapy Trial (HMM0301) on November 12
November 8, 2019 -
GlobeNewswire
Tempest Therapeutics’ Oncology Programs Presented at Society of Immunotherapy for Cancer Annual Meeting
November 8, 2019 -
PR Newswire
TraceLink Ranked #298 Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500™
November 7, 2019 -
GlobeNewswire
Orchard Therapeutics Reports Third Quarter 2019 Financial Results and Achievement of Key 2019 Milestones for Neurometabolic and Primary Immune Deficiencies Franchises
November 6, 2019 -
GlobeNewswire
Unum Therapeutics Presents Preclinical Data for BOXR1030 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 5, 2019 -
BioSpace
Checkmate Pharmaceuticals Presents Positive Clinical Data with CMP-001 at The 34th Annual Meeting of The Society for Immunotherapy of Cancer (SITC)
November 5, 2019 -
GlobeNewswire
Unum Therapeutics Announces Strategic Focus on Developing Best-in-Class Cellular Therapies for Solid Tumor Cancers
November 4, 2019 -
PR Newswire
Iora Primary Care Recognizes National Alzheimer’s Awareness and Family Caregivers Months with Educational Workshops Across the Country
November 4, 2019 -
Business Wire
Beam Therapeutics Announces Collaboration and Exclusive License Agreement with Prime Medicine for Prime Editing Technology
October 31, 2019 -
PR Newswire
Embark and VetBloom Collaborate to Create Inaugural Canine Genomics E-Learning Courses
October 31, 2019 -
PR Newswire
Promentis Pharmaceuticals Announces Positive Results for Phase 2A Study of SXC-2023 Targeting Novel Glutamatergic Mechanism and Completion of Enrollment for Phase 2 Trichotillomania Study
October 31, 2019 -
Business Wire
Checkmate Pharmaceuticals Announces Appointment of Kleem Chaudhary as Chief Business Officer
October 31, 2019 -
GlobeNewswire
Lumere’s Category Optimization Solution Named 2019 Chicago Innovation Award Winner
October 29, 2019 -
PR Newswire
Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences
October 26, 2019 -
PR Newswire
TraceLink Appoints Merck KGaA Thought Leader to Drive Strategy for Deployment of Advanced Analytics across Life Sciences Industry
October 24, 2019 -
Business Wire
Compass Therapeutics to Present Preclinical Data on a Novel PD-1/PD-L1 Bispecific Antibody and from its Proprietary Innate Cell Engager Platform at the 2019 SITC Meeting
October 24, 2019 -
dotmed
Ivenix partners with Iatric Systems to deliver auto-pump programming to MEDITECH hospitals
October 23, 2019 -
GlobeNewswire
Orchard Therapeutics Presents Data from OTL-200 in Patients with Metachromatic Leukodystrophy Using Cryopreservation
October 23, 2019 -
BioSpace
Compass Therapeutics Appoints Leading Immuno-Oncology Researchers to Its Immuno-Oncology Scientific Advisory Board
October 22, 2019 -
PR Newswire
Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965
October 21, 2019 -
PR Newswire
Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma
October 20, 2019 -
PR Newswire
Insilico Medicine and ChemDiv form a strategic drug discovery service alliance
October 16, 2019 -
Business Wire
Bozeman Health Engages Kyruus to Support its Digital Transformation and Integrate Patient Access System-wide
October 15, 2019 -
BioSpace
Checkmate Pharmaceuticals Announces Additions to Management Team
October 15, 2019 -
GlobeNewswire
Ultragenyx Announces FDA Accepts New Drug Application for UX007 (triheptanoin) for Treatment of Long-chain Fatty Acid Oxidation Disorders
October 14, 2019 -
BioSpace
Menlo Therapeutics Presents Successful Phase 2 Clinical Trial Results of Serlopitant in Psoriasis at the European Academy of Dermatology and Venereology Meeting
October 11, 2019 -
PR Newswire
Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors
October 10, 2019 -
PR Newswire
Protenus Focuses on Customers and Compliance With New Additions of Chief Customer Officer and Vice President of Legal
October 10, 2019 -
Business Wire
Beam Therapeutics Appoints Graham Cooper to Board of Directors
October 10, 2019 -
PR Newswire
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million
October 9, 2019 -
GlobeNewswire
Adaptimmune and Cryoport Announce Agreement to Ensure Safe and Fully Monitored Transport of Adaptimmune’s Cell Therapies
October 9, 2019 -
Forbes
AI Startup Working To Target Cancer, Age-Related Disease Gets $37 Million Nod From Top VCs
October 9, 2019 -
Fierce Biotech
Owkin’s mesothelioma AI discovers new biomarkers from lung biopsy images
October 7, 2019 -
Business Wire
Lafayette General Health to Elevate Consumer Digital Experience and Launch Online Scheduling with Kyruus
October 7, 2019 -
CNBC
Private Medicare plan Devoted Health says it is the first to cover Apple Watch as a benefit
October 7, 2019 -
GlobeNewswire
Tempest Therapeutics Names Biopharmaceutical Executive Stephen Brady as President and Chief Operating Officer
October 7, 2019 -
PRWeb
Vitalware’s Tara Bradley Named Finalist in 16th Annual Stevie® Awards for Women in Business
October 7, 2019 -
VerveTx
Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as Chief Scientific Officer
October 3, 2019 -
Business Wire
Banner Health Launches Online Scheduling for Consumers with Kyruus
October 3, 2019 -
MobiHealthNews
Cloud management tool for dental practices CareStack lands $28M
October 2, 2019 -
GlobeNewswire
Unum Therapeutics Announces Data Presentation at the Upcoming Society for Immunotherapy of Cancer (SITC) Meeting
October 2, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Appointment of CEO Mark Rothera to The Alliance for Regenerative Medicine’s 2020 Board of Directors
October 2, 2019 -
GlobeNewswire
Unum Therapeutics Announces Data Presentation at the Upcoming Society for Immunotherapy of Cancer (SITC) Meeting
October 2, 2019 -
PR Newswire
TraceLink Announces New Digital Network Platform to Further Transform the Global Pharmaceutical Supply Chain
October 2, 2019 -
GlobeNewswire
Tempest Therapeutics Announces Multiple Presentations at Upcoming Sitc 34th Annual Meeting
October 2, 2019 -
Business Wire
Checkmate Pharmaceuticals Announces Dosing of First Patient in a Phase 1b/2 Study in Squamous Cell Carcinoma of the Head and Neck with Lead Investigational Candidate CMP-001
October 1, 2019 -
PR Newswire
Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer
October 1, 2019 -
Oxford Nanopore
Oxford Nanopore enters into a non-exclusive agreement with Caribou Biosciences for CRISPR-Cas9 enrichment for nanopore sequencing
September 30, 2019 -
GlobeNewswire
Menlo Therapeutics Announces Completion of Enrollment of 233 Patients in Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin
September 30, 2019 -
GlobeNewswire
Ultragenyx and Kyowa Kirin Announce U.S. FDA Approves Label Update for Crysvita® (burosumab) for the Treatment of X-Linked Hypophosphatemia (XLH)
September 30, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Presentation of New Clinical Data for OTL-200 for Metachromatic Leukodystrophy at Upcoming European Society of Gene & Cell Therapy Annual Congress
September 30, 2019 -
Business Standard
Eywa aims to make mark in US market with own label, skip generic trend
September 28, 2019 -
GlobeNewswire
Acacia Pharma Announces New BARHEMSYS® PDUFA Target Date of 26 February 2020
September 26, 2019 -
Newswire
Artemis Health Wins 2019 SaaS Award From Appealie
September 26, 2019 -
GlobeNewswire
Precision BioSciences Appoints David Thomson, PhD, as Chief Operating Officer
September 23, 2019 -
Business Wire
Nebula Genomics Launches Anonymous Genetic Testing
September 19, 2019 -
PR Newswire
Innovent Provides Update on the Results of IBI305 for the First-line Treatment of Advanced Non-squamous Cell Lung Cancer by Oral Presentation at CSCO
September 19, 2019 -
PR Newswire
Benchling Launches New Products for Research Institutions and Biotech Startups to Accelerate Life Science Innovation
September 17, 2019 -
genomeweb
LunaPBC Partners With Medfusion to Integrate EHR, Genomic Data-Sharing Platform
September 17, 2019 -
PR Newswire
Firefly Health Closes $10.2 Million Series A Funding Round to Expand New Primary Care and Patient Experience Platform
September 16, 2019 -
GlobeNewswire
Precision BioSciences Announces FDA Clearance of the IND for PBCAR20A, a CD20 Targeting Genome Edited Allogeneic CAR T Therapy
September 16, 2019 -
Business Wire
Verve Therapeutics Appoints Drug Delivery Expert Andrew Geall, Ph.D., to Scientific Advisory Board
September 16, 2019 -
Business Wire
Devoted Health and Publix Team Up to Improve Flu Vaccination Coverage in Florida
September 12, 2019 -
GlobeNewswire
Ultragenyx and Kyowa Kirin Announce Intent to Submit Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) in Tumor-Induced Osteomalacia (TIO)
September 10, 2019 -
BioSpectrum
Insilico Medicine secures $37M in series B funding
September 10, 2019 -
PR Web
CareStack and ClearGage Announce Technology Integration
September 10, 2019 -
GlobeNewswire
Zogenix Completes Acquisition of Modis Therapeutics, Inc.
September 9, 2019 -
GlobeNewswire
United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4
September 9, 2019 -
Fierce Biotech
Insilico’s AI networks generate custom lead compounds for fibrosis in less than 50 days
September 4, 2019 -
GlobeNewswire
Ultragenyx Announces Positive Data from Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
September 4, 2019 -
GlobeNewswire
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website
September 4, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Encouraging Update from Proof-of-Concept Study of OTL-203 for the Treatment of Mucopolysaccharidosis Type I (MPS-I)
September 4, 2019 -
Business Wire
Beam Therapeutics Appoints Financial Industry Veteran, Terry-Ann Burrell, as Chief Financial Officer
September 4, 2019 -
Business Wire
Iora Health and Humana Expand Relationship to Provide More Humana Medicare Advantage Plan Members Access to Additional Coordinated Care in Arizona, Georgia and Texas
September 4, 2019 -
Fierce Biotech
Biotech Vertex plunks down $950M for stem cell player Semma Therapeutics
September 3, 2019 -
GlobeNewswire
GeneTx and Ultragenyx Announce Orphan Drug Designation and Rare Pediatric Disease Designation for GTX-102
September 3, 2019 -
GlobeNewswire
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients
August 27, 2019 -
PR Newswire
Iora Primary Care to Open Five Practices Offering Quality Care for Adults on Medicare
August 26, 2019 -
Fierce Biotech
Zogenix pays $250M upfront for startup Modis and its FDA ‘breakthrough’ med
August 26, 2019 -
Endpoint News
Modis Therapeutics -$30M launch round to $400M buyout deal — with $250M upfront — in 10 short months
August 26, 2019 -
PR Newswire
Avidity Biosciences Adds Drug Development Veterans Edward Kaye and Noreen Henig to Board of Directors
August 22, 2019 -
PR Newswire
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
August 21, 2019 -
Newswire
Healthcare Embracing New Era of Compliance and Analytics
August 20, 2019 -
STAT
Can targeting one protein complex solve multiple diseases? NodThera is betting on it
August 16, 2019 -
PR Newswire
Vitalware Named to the 2019 Inc. 5000 Fastest Growing Private Companies List for Fifth Consecutive Year
August 15, 2019 -
GlobeNewswire
Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
August 14, 2019 -
PR Newswire
Iora Health Hires New Chief Operating Officer, Suzanne Hansen
August 13, 2019 -
Business Wire
Kyruus ProviderMatch® Patient Access Platform Now Powering Patient-Provider Matching at Norton Healthcare
August 6, 2019 -
PR Newswire
Innovent and Shenogen Announce Collaboration to Evaluate Tyvyt® (Sintilimab injection) in Combination with SNG1005 for the Treatment of Patients with Advanced Cancer
August 5, 2019
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.